Achieve Life Sciences (ACHV) FCF Margin (2011 - 2013)

Achieve Life Sciences (ACHV) recorded quarterly FCF Margin of 120.35% in Q2 2013, up 43.17% on a QoQ basis from 211.78% in Q1 2013, and up 44957.0% year-over-year from N/an in Q2 2012.

Achieve Life Sciences (ACHV) FCF Margin (2011 - 2013) Analysis & Trends

Achieve Life Sciences has disclosed FCF Margin across 3 years of filings, most recently posting 120.35% for Q2 2013.

  • Quarterly FCF Margin rose 44957.0% year-over-year to 120.35% in Q2 2013, while the trailing twelve-month figure through Jun 2013 was 147.54% (up 37219.0% YoY) and the FY2012 annual result came in at 217.83%, up 15202.0% from the prior year.
  • FCF Margin climbed to 120.35% in Q2 2013, from 211.78% in the prior quarter.
  • Over five years, FCF Margin peaked at 98.71% in Q4 2012 and troughed at 569.92% in Q2 2012.
  • A 3-year average of 327.55% and a median of 296.0% in 2011 frame the typical range for FCF Margin.
  • Annual changes were most pronounced in 2012 — FCF Margin plunged 27392 bps — and 2013, when it soared 44957 bps.
  • Tracing ACHV's FCF Margin over 3 years: stood at 370.25% in 2011, then surged by 73 bps to 98.71% in 2012, then decreased by 22 bps to 120.35% in 2013.
  • Business Quant data shows ACHV's FCF Margin at 120.35% in Q2 2013, 211.78% in Q1 2013, and 98.71% in Q4 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -3.98%
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 43.35%
9 Abivax 91.71 Bn 91.71 Bn - -
10 Achieve Life Sciences 93.71 Mn 63.22 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2013 -120.35%
Mar 31, 2013 -211.78%
Dec 31, 2012 -98.71%
Sep 30, 2012 -196.36%
Jun 30, 2012 -569.92%
Mar 31, 2012 -567.92%
Dec 31, 2011 -370.25%
Sep 30, 2011 -516.67%
Jun 30, 2011 -296.00%